Top compounds associated with response to TMA7


Feature Type Standardized
Nominal ANOVA
mRNA paclitaxel gCSI pan-cancer AAC 0.027 0.6
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.018 0.6
mRNA tamatinib CTRPv2 pan-cancer AAC -0.019 0.6
mRNA lapatinib CTRPv2 pan-cancer AAC -0.018 0.6
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.6
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA bendamustine CTRPv2 pan-cancer AAC 0.019 0.6
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC -0.023 0.6
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.018 0.6
Download CSV